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Abstract
Background: Differences in prevalence of cardiometabolic risk factors between different ethnic
groups are largely unknown. We determined the variation in cardiometabolic risk profile according
to ethnicity in a cohort overweight/obese Dutch children.
Methods: An oral glucose tolerance test was performed in 516 overweight/obese Dutch children
of multi-ethnic origin, attending an obesity out-patient clinic of an urban general hospital (mean age
10.6 ± 3.2; 55.2% boys). Anthropometric parameters and blood samples were collected, and the
prevalence of (components of) the metabolic syndrome (MetS) and insulin resistance were
determined in each ethnic group.
Results: Major ethnic groups were Dutch native (18.4%), Turkish (28.1%), and Moroccan (25.8%).
The remaining group (27.7%) consisted of children with other ethnicities. Turkish children had the
highest mean standardized BMI compared to Dutch native children (P < 0.05). As compared to
Moroccan children, they had a higher prevalence of MetS (22.8% vs. 12.8%), low HDL-cholesterol
(37.9% vs. 25.8%), hypertension (29.7% vs. 18.0%) and insulin resistance (54.9% vs. 37.4%, all P <
0.05). Although Turkish children also had higher prevalences of forementioned risk factors than
Dutch native children, these differences were not statistically significant. Insulin resistance was
associated with MetS in the Turkish and Moroccan subgroup (OR 6.6; 95%CI, 2.4–18.3 and OR 7.0;
95%CI, 2.1–23.1, respectively).
Conclusion: In a Dutch cohort of overweight/obese children, Turkish children showed
significantly higher prevalences of cardiometabolic risk factors relative to their peers of Moroccan
descent. The prospective value of these findings needs to be established as this may warrant the
need for differential ethnic-specific preventive measures.
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Currently 10.6% of the Dutch population consists of non-
Western immigrants, with people of Turkish (21.2%),
Surinamese (19.2%) and Moroccan descent (19.0%)
being the major minority groups [1]. The globally increas-
ing prevalence of obesity and its accompanying health
risks, such as type 2 diabetes mellitus and cardiovascular
disease (CVD) [2-4], concerns all racial groups, including
the aforementioned minority groups. Compared to the
inhabitants of their country of origin, immigrant groups
often have increased risk of developing CVD. For exam-
ple, data on Japanese immigrants living in the United
States indicate that a westernized lifestyle aggravates the
risk factors for atherosclerosis and its progression [5].
Although a limited number of studies have directly exam-
ined the extent to which the prevalence of obesity and car-
diometabolic risk factors vary by ethnicity, certain ethnic
groups have been identified as having a greater suscepti-
bility for CVD [6]. A recent study in the Netherlands
found that female Turkish and Moroccan migrants had a
two-to-three fold higher risk of being overweight [7], and
similar differences have been reported in Turkish and
Moroccan children in comparison with Dutch native chil-
dren [8]. Apart from overweight, little is known about the
prevalence of cardiometabolic risk factors in children
among ethnic groups in the Netherlands. Studies on car-
diometabolic risk factors which compared Dutch native
and Non-Western migrant adults showed a lower preva-
lence of dyslipidaemia and a higher prevalence of diabetes
and CVD among Turks, whereas the prevalence of CVD
was lower in Moroccans, despite the higher prevalence of
diabetes [7,9]. Ethnic differences may already be present
in migrant children and could predict the risk of obesity
and CVD in adulthood. Indeed, a number of studies have
stressed the relevance of cardiometabolic risk factors at a
young age for the development of CVD in later life [10-
13].
A way to estimate cardiometabolic risk in both adults and
children is to identify the presence of (components of) the
'metabolic syndrome' (MetS), a clustering of cardiometa-
bolic disorders, including (central) obesity, impaired glu-
cose metabolism, hypertension and dyslipidaemia [14-
16]. In the various available definitions of MetS, adjust-
ment for ethnicity is not applied, while on bases of previ-
ously found differences in prevalence of MetS among
ethnic adult populations, adjustment may be required
[13].
In the present study, we determined the prevalence of the
metabolic syndrome and its components, according to a
paediatric definition, in three major ethnic groups in a
Dutch multi-ethnic cohort of obese and overweight chil-
dren.
Methods
Study population and study protocol
In the period 2004–2008, data from a cohort children
(aged 3–18 years), who were overweight or obese (Z-BMI
≥ 1.1) and who visited an urban general hospital in
Amsterdam (Slotervaart Hospital), were collected accord-
ing to a prevailing treatment protocol. Children with (sus-
pected) syndromes and with type 1 diabetes or with
secondary causes of obesity such as hypothyroidism,
hypogonadism and pituitary disorders, or children who
used glucose- or lipid-lowering medication, corticoster-
oids (chronically) or drugs acting on the central nervous
system, were excluded from the study. All subjects had no
history of alcohol abuse and serologic tests for hepatitis B
or C virus were all negative. In total, 516 children of
multi-ethnic origin, who were overweight or obese, were
included in the study.
During the first visit, a detailed history and physical exam-
ination was performed, including blood pressure meas-
urements, and assessment of height, weight, waist
circumference, and pubertal stage according to Tanner
[17]. Waist circumference was measured in accordance
with a previously described method [10]. During the sec-
ond visit, each child underwent an oral glucose tolerance
test (OGTT; 1.75 g/kg with a maximum of 75 g). Blood
samples for lipid levels, insulin, and glucose were taken
before the OGTT (fasting levels) and two hours after glu-
cose intake (glucose only).
Definitions
Ethnicity was defined as Dutch if both parents were Dutch
native, and Moroccan or Turkish in case both parents were
from that specific country. Children with other ethnici-
ties, and children with parents of different origins were
collected in a separate group, hereafter referred to as the
'other' group. This group comprises children from areas
all over the world i.e. Africa (Egypt, Somalia, Senegal,
Ghana, Congo), The Caribbean (Dominican Republic,
Suriname, Jamaica, Antilles), South America (Argentina,
Chile), Middle East (Lebanon, Iraq, Iran), South Asia
(India, Pakistan, Kurdistan, Sri Lanka), South East Asia
(Philippines, Indonesia), China and Europe (Portugal,
Bosnia). This brings the total number of ethnicities in this
group to about twenty-three, which leaves too small num-
bers per ethnic group to analyse separately.
BMI was standardized using Z-scores (Z-BMI) according
to Dutch reference values for Dutch native, Turkish and
Moroccan children [18-20]. Waist circumference meas-
urements were standardized according to Dutch reference
values (Z-WC) [21]. Impaired glucose tolerance (IGT) was
defined as a 2 h-glucose ≥ 7.8 and <11.0 mmol/L and
impaired fasting glucose (IFG) was defined as a fasting
glucose 5.6 to 6.9 mmol/L [13]. Lipid levels were evalu-Page 2 of 9
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with cut-off points above the 95th percentile for total cho-
lesterol, LDL-cholesterol and triglycerides, and below the
5th percentile for HDL-cholesterol. Blood pressure values
were considered abnormal when values were above the
95th percentile, according to European reference values for
height and sex [23].
MetS was diagnosed according to the definition proposed
by Weiss et al on defining MetS in children and adoles-
cents [13]. MetS was established when three or more of
the following criteria were present: obesity (BMI above
97th percentile for age and sex), a triglyceride level above
the 95th percentile [22], an HDL-cholesterol level below
the 5th percentile [22], a diastolic or systolic blood pres-
sure above the 95th percentile [23], and IGT. Insulin resist-
ance was calculated according to the Homeostasis Model
Assessment for Insulin Resistance (HOMA-IR): fasting
plasma insulin (μU/L) × fasting glucose (mmol/L)/22.5
[24]. Insulin resistance was defined as HOMA-IR ≥ 3.5
[25]. Pancreatic β-cell function was expressed as HOMA-
B, computed as (20 × insulin (μU/L))/(fasting glucose
(mmol/L) – 3.5) [24].
Laboratory analyses
Plasma glucose levels and fasting triglyceride, HDL-cho-
lesterol and total cholesterol levels were measured by the
SYNCHRON LX 20 (Beckman Coulter, USA). Low-density
lipoprotein (LDL-) cholesterol was calculated with the
Friedewald-formula [26]. Plasma insulin levels were
measured by an immunoluminometric assay (Immulite
200 system, DPC, Los Angeles, USA; intra-assay variation:
3–6%, inter-assay variation: 3–5%).
Statistical analyses
Mean (standard deviation), median (interquartile range)
or percentages are shown. Results were stratified by ethnic
group. Differences between group proportions were ana-
lyzed by χ2 tests, and differences between groups were
analyzed by analyses of variance (ANOVA) with post-hoc
Bonferroni tests or by independent Student's t-tests. Vari-
ables with a skewed distribution were log transformed for
the analyses. Logistic regression analysis was performed to
assess the associations between insulin resistance and
(components of) MetS. Results of these analyses are
expressed as odds ratios (OR) and 95% confidence inter-
vals (95%CI). To identify possible confounders in these
analyses, we introduced sex, age, pubertal stage and Z-BMI
stepwise. Aforementioned variables were considered con-
founders when causing a change in the regression coeffi-
cient beta of more than 10%.
A P-value < 0.05 was considered statistically significant.
All analyses were performed with SPSS, version 15.0 (for
Windows).
Results
Baseline characteristics
The cohort consisted of 516 children (55.2% boys, 41.5%
prepubertal, mean age 10.6 ± 3.2 years), with the main
ethnic groups being Dutch native (18.4%), Turkish
(28.1%), Moroccan (25.8%), and a group consisting of at
least 23 ethnicities all represented by relatively small
numbers of children, designated as 'other' (27.7%). Due
to the small numbers of the respective ethnic groups in
the 'other' group, no separate analyses could be made, but
to provide a complete overview the data of this mixed
group is also included in the Tables and Graphs.
Table 1 shows the baseline characteristics of the three
main ethnic groups. Dutch native children had the lowest
mean Z-BMI, compared to Turkish children (2.6 ± 0.5 vs.
2.8 ± 0.5, P = 0.024). Turkish children and children in the
'other' group had highest fasting insulin levels, HOMA-IR,
HOMA-B and triglycerides as compared to Moroccan chil-
dren (all P < 0.05). In addition, Turkish children had low-
est HDL-cholesterol levels (P = 0.007) and highest
diastolic blood pressure (P = 0.015), compared to their
Moroccan peers.
The difference in mean LDL-cholesterol levels between
Dutch native children and Moroccan children was border-
line significant (P = 0.054).
Prevalence of (components of) the metabolic syndrome
Obesity according to the criterion of MetS (BMI above
97th percentile for age and sex) was present in 83.2% of
Dutch native, 69.0% in Turkish, 80.5% in Moroccan and
81.1% in 'other' children. Overall, MetS was present in
16.9%, IGT in 3.2%, low HDL-cholesterol in 31.2%, high
triglycerides in 17.4% and hypertension in 22.9% of all
children. Only three children were diagnosed with type 2
diabetes. There were no differences in prevalence of MetS
or its components when stratified for sex in each of the
three ethnic groups, however, MetS and the prevalence of
low HDL-cholesterol were more abundant among puber-
tal children, compared to prepubertal children (20.2% vs.
12.1%, P = 0.017 and 35.4% vs. 25.2%, P = 0.016, respec-
tively). Figure 1 shows the prevalence of MetS and its dif-
ferent components according to ethnicity. The largest
differences were found between the Turkish and Moroc-
can groups, and these reached statistical significance for
MetS, low HDL-cholesterol and hypertension (all P <
0.05). High triglycerides tended to be less prevalent in
Moroccan children than in Dutch natives (P = 0.07). Fig-
ure 2 shows the number of components stratified for eth-
nicity, and reveals no difference in the prevalence of
having no MetS-components. When the obesity criterion
of MetS was excluded from the analysis, 60.9% of Moroc-
can children, relative to 48.8% of Dutch native childrenPage 3 of 9
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nents (P = 0.007).
Impaired fasting glucose, insulin resistance, and high LDL-
cholesterol according to ethnicity
Overall, fasting glucose levels of ≥ 5.6 mmol/L were
present in 23.1%, and insulin resistance in 48.8% of chil-
dren. Both were more prevalent in pubertal children,
compared to prepubertal children (26.8% vs. 17.8%, P =
0.019 and 62.3% vs. 26.1%, P < 0.001, respectively).
Regarding ethnic-specific differences, highest rates of
insulin resistance were found in Turkish children
(54.9%), while the prevalence was 49.4% in the 'other'
group, 46.8% in the Dutch native group and 37.4% in the
Moroccan group, with the difference between the Turkish
and Moroccan group being significant (P = 0.005) and the
difference between the 'other' group and the Moroccan
group being borderline significant (P = 0.052). In addi-
tion, Turkish children had highest HOMA-B levels, in
comparison with Moroccan children (Table 1). High LDL-
cholesterol (from highest to lowest prevalence) among
groups was present in 28.4% of Dutch native children,
19.7% of children with 'other' ethnicities, 14.5% of Turk-
ish children and 10.6% of Moroccan children. The differ-
ence between Dutch native children and Moroccan
children was significant (P = 0.001), as was the difference
Table 1: Anthropometric and cardiometabolic characteristics according to ethnicity
Dutch Native Turkish Moroccan Other P-value
N (%) 95 (18.4) 145 (28.1) 133 (25.8) 143 (27.7) -
Male (%) 49.5 60.7 56.4 52.4 0.19
Pubertal (%) 55.8 63.4 57.1 56.6 0.80
Age (years) 11 ± 3 11 ± 3 10 ± 3 11 ± 3 0.23
Z-BMI 2.6 ± 0.5 2.8 ± 0.5* 2.8 ± 0.5 2.8 ± 4.5 0.03
Z-WC 3.8 ± 1.2 4.1 ± 1.1 3.9 ± 1.3 3.8 ± 1.0 0.16
SBP (mmHg) 116 ± 11 116 ± 12 113 ± 11 115 ± 12 0.11
DBP (mmHg) 71 ± 8 73 ± 9† 70 ± 8 71 ± 8 0.02
Fasting plasma glucose (mmol/L) 5.2 ± 0.4 5.3 ± 0.4 5.3 ± 0.4 5.3 ± 0.4 0.17
2-h plasma glucose (mmol/L) 5.8 ± 0.9 5.9 ± 1.0 5.7 ± 0.9 5.9 ± 1.0 0.083
Fasting plasma insulin (pmol/L) 95 (65–165) 112 (83–167)‡ 90 (58–138) 112 (71–188)† 0.002
HOMA-IR 3.1 (2.0–5.4) 3.6 (2.6–5.7)‡ 3.0 (1.8–4.7) 3.5 (2.4–6.1)† 0.003
HOMA-B 159 (109–258) 177 (120–251)‡ 138 (99–204) 174 (112–288)† 0.004
Total cholesterol (mmol/L) 4.4 ± 0.9 4.3 ± 0.8 4.2 ± 0.8 4.4 ± 0.7 0.23
HDL-cholesterol (mmol/L) 1.1 (0.9–1.2) 1.0 (0.9–1.2)‡ 1.1 (0.9–1.3) 1.0 (0.9–1.2) 0.014
LDL-cholesterol (mmol/L) 2.8 ± 0.6 2.8 ± 0.7 2.7 ± 0.7 2.9 ± 0.6 0.075
Triglycerides (mmol/L) 0.9 (0.6–1.3) 0.9 (0.6–1.3)‡ 0.7 (0.5–1.0) 1.1 (0.7–1.2)† 0.004
Data are mean ± SD and n (%) or median (interquartile range) for variables with a skewed distribution. P-values are given for comparisons between 
ethnic groups, tested with ANOVA.
SD-standard deviation; Z-BMI-standard deviation score of BMI; Z-WC-standard deviation score of waist circumference; HOMA-IR-Homeostasis 
Model Assessment for Insulin Resistance; HOMA-B-Homeostatis Model Assessment for pancreatic β-cell function
*P < 0.05 compared to Dutch native children, †P < 0.05 compared to Moroccan children, ‡P < 0.01 compared to Moroccan children.Page 4 of 9
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0.013) and between the 'other' and the Moroccan group
(P = 0.044).
Association of insulin resistance with (components of) the 
metabolic syndrome and impaired fasting glucose
Table 2 shows the association of insulin resistance
(HOMA-IR <3.5 vs. ≥ 3.5) with (components of) MetS
and IFG, stratified for the three major ethnic groups, after
Prevalence of the metabolic syndrome (A), low HDL-cholesterol (B), high triglycerides (C), hypertension (D), impaired glucose tolerance (E) and i p ired fasting glucose (F) according to ethnicity; Dutch native (white bars), Turkish (light grey bars), Moroccan (dark grey bars), nd 'other' (black bars)Figur  1
Prevalence of the metabolic syndrome (A), low HDL-cholesterol (B), high triglycerides (C), hypertension (D), 
impaired glucose tolerance (E) and impaired fasting glucose (F) according to ethnicity; Dutch native (white 
bars), Turkish (light grey bars), Moroccan (dark grey bars), and 'other' (black bars). * χ2 test, all P < 0.05.Page 5 of 9
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confounders (sex, age and/or Z-BMI). IGT was not
included into the analyses due to the very low prevalence,
however, insulin resistance was associated with IFG in all
ethnic groups. Besides the forementioned association, in
Moroccan children, insulin resistance was associated with
MetS and its components named in Table 2. In Turkish
children, insulin resistance was associated with MetS and
low HDL-cholesterol, whereas in the 'other' group, it was
associated with MetS and high triglycerides. In the Dutch
native group, insulin resistance was only significantly
associated with high triglycerides.
Discussion
This is the first study to compare cardiometabolic risk pro-
files among different ethnic groups of overweight/obese
children living in the Netherlands. In all ethnic groups, a
high prevalence of MetS and its components were found,
in addition to insulin resistance and high LDL-choles-
terol. Highest prevalences of (components of) MetS and
insulin resistance were found in Turkish children. In con-
trast, Moroccan children seem to have a more favourable
cardiometabolic risk profile. These findings are in line
with the results of a previous Dutch study among adults,
in which a higher prevalence of CVD among Turks and a
lower prevalence of CVD among Moroccans (living in the
Netherlands) were found [7]. In a recent study in children
and adolescents by Weiss et al, differences in adaptation to
insulin resistance among three ethnic groups in the
United States were found. It was suggested that obese Afri-
can American and Hispanic youth had a greater demand
on β-cells to maintain glucose levels, while having the
same insulin sensitivity, compared to Caucasians [27]. In
the present study, we found highest median HOMA-B val-
Prevalences of number of components of the metabolic syndrome; no components (A), one component (B), two components (C), nd three or ore compone ts (D) according t  ethnic group; Dutch nativ  (white bars), Turkish (light grey bars), Moroc-can (dark gr y bars), and 'other' (black b rs)Figur  2
Prevalences of number of components of the metabolic syndrome; no components (A), one component (B), 
two components (C), and three or more components (D) according to ethnic group; Dutch native (white 
bars), Turkish (light grey bars), Moroccan (dark grey bars), and 'other' (black bars). * χ2 test, P < 0.05. † χ2 test, P < 
0.001.Page 6 of 9
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highest within this group. If the former finding would per-
severe throughout adulthood, it could partially explain
the higher prevalence of type 2 diabetes mellitus found
among people of Turkish origin living in the Netherlands
[9].
We found a markedly lower prevalence of MetS as com-
pared to the study by Weiss et al, in children of compara-
ble age, who described a prevalence of 38.7% (moderately
obese subjects) to 49.7% (severely obese subjects), apply-
ing the same definition [13]. This difference in prevalence
of MetS is probably attributable to the different ethnic
background and weight status of both cohorts.
Between different ethnic groups among an adult popula-
tion, a varying prevalence of MetS was found when apply-
ing one definition of MetS [28]. In addition, an
inconsistent relationship between MetS and CVD was
reported, with some populations with low prevalence of
MetS carrying a high CVD risk [29]. These discrepancies
implicate that different ethnic groups require appropriate
reference values in order to establish cardiometabolic
abnormalities as well as specific combinations of MetS cri-
teria to predict cardiometabolic risk more reliably, taking
into account specific vulnerabilities [29].
There were no statistical significant differences in the per-
centage pubertal children between the ethnic groups.
Moreover, we found similar trends after stratification for
pubertal status and ethnic group, however, a formal suba-
nalysis could not be made due to the small size of the sub-
groups within each ethnic group. We found a similar
HOMA-IR in the Turkish and 'other' group, while the
'other' group had a lower percentage of pubertal children
in an absolute sense. The former only attributes to the
assumption that the degree of insulin resistance is not
caused by puberty alone. Although normal puberty is
associated with hyperinsulinaemia, it is unclear when this
physiological phenomenon becomes pathological i.e.
with development of sustained insulin resistance and its
related cardiometabolic risk factors [30]. After puberty,
the presence of these risk factors may in part resolve, how-
ever, one should bare in mind that the presence of MetS
during childhood and puberty predicts the presence of
MetS and type 2 diabetes in later life [11]. Therefore, the
assessment of only insulin resistance parameters in these
children may be less reliable to evaluate CVD risk, but
rather an overall assessment of cardiometabolic risk fac-
tors should be performed in clinical practice. In the logis-
tic regression analyses, pubertal stage was identified as a
confounder for the association between insulin resistance
and cardiometabolic risk factors. However, since puberty
and age are highly correlated, we choose to include age
into the analysis, to avoid collinearity of these two varia-
bles within the regression analyses. To note, when using
puberty instead of age within the models, similar results
were found.
In spite of the fact that Turkish children were least likely
to fulfil the obesity criterion of MetS according to Dutch-
Turkish reference values, they had highest prevalences of
cardiometabolic risk factors. This gives rise to the question
whether with the use of current reference values, obesity
and MetS in this group are underdiagnosed, which would
indicate that the prevalence of MetS would even be higher
in this group. Some of the differences found may be attrib-
uted to environmental factors, such as socio-economic
status, lifestyle and diet. However, regarding differences in
diet among ethnic groups, its influence may be ques-
Table 2: Associations of insulin resistance with (three components of) MetS and IFG
Dutch Native Turkish Moroccan Other
n (%) 95 (18.4) 145 (28.1) 133 (25.8) 145 (27.7)
MetS 2.1 (0.8–6.9)c 5.0 (1.7–14.6)*c 7.0 (2.1–23.1)* 3.3 (1.2–8.9)†
IFG 5.0 (1.5–16.7)* 3.1 (1.3–7.2)*a 5.4 (2.3–12.9)* 4.8 (1.6–13.9)*a, b
Low HDL-cholesterol 1.4 (0.5–3.5)c 4.5 (2.1–9.6)* 3.1 (1.1–8.9)†b, c 2.1 (0.9–4.8)b
High Triglycerides 3.8 (1.3–10.9)† 2.4 (0.9–6.3)c 5.2 (1.3–20.4)†b 4.1 (1.3–12.9)†b
Hypertension 1.2 (0.4–3.5)a, b, c 0.7 (0.3–1.6)b, c 6.2 (1.8–21.1)*b 1.4 (0.5–3.6)a, b
Odds ratios (95% confidence intervals) are given for the associations of insulin resistance (binary variable) with the components comprising MetS 
and IFG (after adjustment for confounders; asex, bage, cZ-BMI), with logistic regression analysis.
*P < 0.01
†P < 0.05
HOMA-IR-Homeostasis Model Assessment for Insulin Resistance; MetS-metabolic syndrome; IFG-Impaired Fasting Glucose, IGT-Impaired Glucose 
IntolerancePage 7 of 9
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children have a diet which is more in line with the Dutch
guidelines for a healthy diet than the conventional diet as
consumed by Dutch native children [31]. The latter does
not support the finding that Turkish children have the
most unfavourable cardiometabolic risk profile overall,
but may account, at least in part, for the relatively low
LDL-cholesterol levels in Turkish and Moroccan children.
Adaptation of a Western lifestyle after migration is consid-
ered by some as major cause of overweight and develop-
ment of other cardiometabolic risk factors, since the
prevalence of these factors is often lower in the country of
origin [32]. At least this applies for Turkish adults, but sur-
prisingly, in a cohort of two thousand Moroccan adults
living in Morocco, the prevalence of dyslipidaemia and
hypertension was respectively three and four fold with
respect to Moroccans living in the Netherlands [7,32].
Although confounding factors, such as low socio-eco-
nomic status and limited access to health care providers in
the country of origin may play a role, these findings pre-
clude a reliable assessment of the true contribution of
Western lifestyles on the prevalence of cardiometabolic
risk factors in Moroccan immigrants.
As shown previously, environmental factors can only
partly explain differences found among racial groups, so it
is likely that genetic profile plays a key role in expression
of obesity related co-morbidities [33], i.e. it is known that
the Hindu population in particular carries high risk on
diabetes and cardiometabolic risk factors [34]. Genetic
influence is also supported by our finding that insulin
resistance is differently associated with cardiometabolic
risk factors per ethnic group.
In the present study, the group with various 'other' ethnic-
ities revealed significantly higher fasting insulin levels and
HOMA-IR as compared to Moroccan children. Addition-
ally, a higher prevalence of cardiometabolic risk factors,
such as dyslipidaemia, was found in this group, as com-
pared to Dutch native and Moroccan children. It is likely
that the various ethnic groups within this rest-group differ
with respect to the prevalence of cardiometabolic risk fac-
tors, however, due to the relative small numbers, the exact
contribution of each ethnicity to the overall group find-
ings cannot be determined. We suspect that the relatively
large number of Hindus within this group caused the high
prevalence of cardiometabolic risk factors. The latter
emphasizes the importance of ethnic specific risk assess-
ment in these groups.
A limitation of our study is its cross-sectional nature, with
data from a single cohort of children in a specific area in
the Netherlands. Therefore, our results cannot be
extended to the general population. However, we believe
that our results may have an important implication given
the demographic changes in other parts of the Nether-
lands. Another limitation is the limited predictive value of
our results, since the predictive value of cardiometabolic
risk factors in childhood on CVD in adulthood is yet to be
established. Also, the contribution of different cardiomet-
abolic risk factors to morbidity and mortality in different
racial groups remain largely unknown, and the associa-
tion of obesity or cardiometabolic risk factors with disease
may differ per racial group [35].
Conclusion
In a Dutch cohort of overweight/obese children, Turkish
children showed a higher prevalence of cardiometabolic
risk factors relative to their peers of other ethnicities. In
contrast, children of Moroccan background seem to have
a relatively favourable cardiometabolic risk profile. Our
results indicate requirement of an ethnic specific
approach in overweight/obese children. Long-term stud-
ies are needed to establish whether our findings are com-
patible with actual risk of future diabetes and CVD in the
different ethnic populations.
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